+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Serevent"

Bronchodilators Global Market Report 2024 - Product Thumbnail Image

Bronchodilators Global Market Report 2024

  • Report
  • April 2024
  • 175 Pages
  • Global
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Serevent is a brand of salmeterol, a long-acting beta-agonist (LABA) used to treat asthma and chronic obstructive pulmonary disease (COPD). It is used as a maintenance treatment to prevent and reduce the frequency of asthma attacks, and to reduce the severity of COPD symptoms. It is usually taken twice daily, either as an inhaler or a dry powder inhaler. Serevent is part of a class of drugs known as bronchodilators, which work by relaxing the muscles in the airways, allowing air to flow more freely. The Serevent market is a subset of the larger respiratory drugs market, which includes a variety of treatments for asthma, COPD, and other respiratory conditions. These treatments include inhaled corticosteroids, long-acting muscarinic antagonists, and short-acting beta-agonists, as well as other medications. Some companies in the Serevent market include GlaxoSmithKline, Merck, and Novartis. Show Less Read more